Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma Subjects

NCT05173545 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent/Refractory Lymphoma

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome Injection

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.